6-APDB: Difference between revisions
>Unity Created page with "{{SubstanceBox/6-APDB}} {| |- |- | ''Summary sheet: 6-APDB'' |} '''6-APDB''' (also known as '''6-(2-aminopropyl)benzofuran''' or '''benzofury''') is a sti..." |
>Unity mNo edit summary |
||
Line 5: | Line 5: | ||
| ''[[6-APDB/Summary|Summary sheet: 6-APDB]]'' | | ''[[6-APDB/Summary|Summary sheet: 6-APDB]]'' | ||
|} | |} | ||
'''6-APDB''' (also known as '''6-(2-aminopropyl) | '''6-APDB''' (also known as '''6-(2-aminopropyl)-2,3-dihydrobenzofuran''' or '''4-Desoxy-MDA''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic [[research chemical]] of the [[Chemical class::phenethylamine]] and [[Chemical class::benzofuran|benzofuran]] classes. It is a closely related synthetic analogue of [[MDA]] and broadly shares the characteristics of serotonin-selective triple monoamine releasers and [[reuptake inhibitors]] associated with other [[entactogen]]ic or [[empathogen]]ic compounds. | ||
6-APDB was first synthesized and studied in 1993 by [[David E. Nichols]] as a potential non-neurotoxic alternative to [[MDMA]]. It did not come into popular recreational use until over a decade later, where it briefly entered the rave scene and global research chemicals market, in particular the "legal highs" market in the U.K., before its sale and import were subsequently banned. | 6-APDB was first synthesized and studied along with 5-APDB in 1993 by [[David E. Nichols]] as a potential non-neurotoxic alternative to [[MDMA]]<ref> "Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine"|https://www.ncbi.nlm.nih.gov/pubmed/8246240</ref>. It did not come into popular recreational use until over a decade later, where it briefly entered the rave scene and global research chemicals market, in particular the "legal highs" market in the U.K., before its sale and import were subsequently banned. | ||
Because 6-APDB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity as a substitute or replacement for serotonergic [[entactogens]] like [[MDMA]] or [[MDA]], and are typically distributed through the online [[research chemical]]s grey market. | Because 6-APDB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity as a substitute or replacement for serotonergic [[entactogens]] like [[MDMA]] or [[MDA]], and are typically distributed through the online [[research chemical]]s grey market. | ||
Line 13: | Line 13: | ||
==Chemistry== | ==Chemistry== | ||
[[File:Phenethylamine.png|thumb|right|253px|thumb|right|253px||General formula of a phenethylamine molecule]] | [[File:Phenethylamine.png|thumb|right|253px|thumb|right|253px||General formula of a phenethylamine molecule]] | ||
6-APDB, also known as 6-(2-aminopropyl) | 6-APDB, also known as 6-(2-aminopropyl)-2,3-dihydrobenzofuran, is a synthetic molecule of the [[benzofuran]] family. Molecules of this class contain a [[phenethylamine]] core bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at R<sub>α</sub>. | ||
6-APDB does not contain a methyl substitution on R<sub>N</sub>, a motif which it shares with [[MDA]]. It is | 6-APDB does not contain a methyl substitution on R<sub>N</sub>, a motif which it shares with [[MDA]]. It is an analogue of MDA where the heterocyclic 4-position oxygen from the 3,4-methylenedioxy ring has been replaced with a methylene bridge. 6-APDB shares this furan ring with [[5-APDB]], [[5-MAPDB]] and [[6-MAPDB]]. | ||
==Pharmacology== | ==Pharmacology== |